Report of a workshop on malignant lymphoma: a review of molecular and clinical risk profiling
Beate Gleissner(Universitätsklinikum des Saarlandes), M. Dreyling(Ludwig-Maximilians-Universität München), B. Glaß(University of Göttingen), Wolfgang Hiddemann(Christian-Albrechts-Universität zu Kiel), Lorenz Trümper(University of Göttingen), Ralf Küppers(University of Duisburg-Essen), Reiner Siebert(Christian-Albrechts-Universität zu Kiel)
Cited by 18
Related Papers
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)
|The Lancet Oncology|2008|1.1k
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling
|New England Journal of Medicine|2006|1k